Literature DB >> 9136281

Genetic marker of segregation: sickle cell anemia, thalassemia, and racial ideology in American medical writing 1920-1950.

K Wailoo1.   

Abstract

This paper focuses on sickle cell anemia and thalassemia as case studies of genetic disease in America. Before the 1950s, these diseases were perceived by many physicians as closely related (indeed, by some as indistinguishable). Sickle cell anemia was defined by most American physicians as a Mendelian dominant disorder specific to African-Americans. As such, it could be 'spread' by any individual parent 'carrier' through reproduction. This view of the disease fed into (and was supported by) prevalent social concerns about miscegenation and, more generally, the dangers inherent in 'negro blood'. A particularly thorny problem for American physicians was how to explain cases of 'sickle cell anemia in white patients'. The paper examines how views about race, blood, and Mendelian genetics informed broader debates about the nature of hereditary disease and social relations in America from 1910 to 1950.

Entities:  

Mesh:

Year:  1996        PMID: 9136281

Source DB:  PubMed          Journal:  Hist Philos Life Sci        ISSN: 0391-9714            Impact factor:   1.205


  5 in total

1.  Questioning the consensus: managing carrier status results generated by newborn screening.

Authors:  Fiona Alice Miller; Jason Scott Robert; Robin Z Hayeems
Journal:  Am J Public Health       Date:  2008-12-04       Impact factor: 9.308

2.  Investigating Trust, Expertise, and Epistemic Injustice in Chronic Pain.

Authors:  Daniel Z Buchman; Anita Ho; Daniel S Goldberg
Journal:  J Bioeth Inq       Date:  2016-12-22       Impact factor: 1.352

3.  Claude Lévi-Strauss on Race, History, and Genetics.

Authors:  Staffan Müller-Wille
Journal:  Biosocieties       Date:  2010-09-01

Review 4.  Sickle Cell Disease: Advances in Treatment.

Authors:  Renée V Gardner
Journal:  Ochsner J       Date:  2018

5.  Refusing blood transfusions from COVID-19-vaccinated donors: are we repeating history?

Authors:  Jeremy W Jacobs; Lorin A Bibb; Bipin N Savani; Garrett S Booth
Journal:  Br J Haematol       Date:  2021-09-15       Impact factor: 8.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.